| Dr James Matthew Gardner, MD | |
|
613 Campus Dr, Suite 200, Abingdon, VA 24210-9703 | |
| (276) 628-1186 | |
| (276) 628-8507 |
| Full Name | Dr James Matthew Gardner |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 32 Years |
| Location | 613 Campus Dr, Abingdon, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528039054 | NPI | - | NPPES |
| 1528039054 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0101049730 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Savida Health, Pc | 4082809967 | 77 |
News Archive
The American Diabetes Association and Good Measures, LLC today announced a new collaboration to help prevent and delay the onset of type 2 diabetes in the more than 84 million Americans currently living with prediabetes.
Today, The Endocrine Society unveiled its newest journal, Hormones & Cancer. This bi-monthly journal will include research articles covering all aspects of hormone action on cancer causation, progression, dependence, prevention, resistance and treatment.
Researchers at Fred Hutchinson Cancer Research Center, Group Health Research Institute and the University of Washington schools of Public Health and Pharmacy have been selected to lead four projects backed by approximately $16 million in federal stimulus funding for comparative-effectiveness research in cancer.
The November 21 cover story of Forbes magazine profiles Bill Gates, Microsoft founder and co-chair of the Bill & Melinda Gates Foundation, which has focused its global health efforts on vaccine development and distribution, according to the article.
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced positive results from the Phase 1 portion of its Phase 1/1b study of defactinib (VS-6063) in combination with paclitaxel in patients with ovarian cancer that were presented at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston.
› Verified 6 days ago
| Entity Name | Johnston Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104812684 PECOS PAC ID: 6103725668 Enrollment ID: O20040103000016 |
News Archive
The American Diabetes Association and Good Measures, LLC today announced a new collaboration to help prevent and delay the onset of type 2 diabetes in the more than 84 million Americans currently living with prediabetes.
Today, The Endocrine Society unveiled its newest journal, Hormones & Cancer. This bi-monthly journal will include research articles covering all aspects of hormone action on cancer causation, progression, dependence, prevention, resistance and treatment.
Researchers at Fred Hutchinson Cancer Research Center, Group Health Research Institute and the University of Washington schools of Public Health and Pharmacy have been selected to lead four projects backed by approximately $16 million in federal stimulus funding for comparative-effectiveness research in cancer.
The November 21 cover story of Forbes magazine profiles Bill Gates, Microsoft founder and co-chair of the Bill & Melinda Gates Foundation, which has focused its global health efforts on vaccine development and distribution, according to the article.
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced positive results from the Phase 1 portion of its Phase 1/1b study of defactinib (VS-6063) in combination with paclitaxel in patients with ovarian cancer that were presented at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston.
› Verified 6 days ago
| Entity Name | Highlands Community Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396774147 PECOS PAC ID: 8123014966 Enrollment ID: O20040426000408 |
News Archive
The American Diabetes Association and Good Measures, LLC today announced a new collaboration to help prevent and delay the onset of type 2 diabetes in the more than 84 million Americans currently living with prediabetes.
Today, The Endocrine Society unveiled its newest journal, Hormones & Cancer. This bi-monthly journal will include research articles covering all aspects of hormone action on cancer causation, progression, dependence, prevention, resistance and treatment.
Researchers at Fred Hutchinson Cancer Research Center, Group Health Research Institute and the University of Washington schools of Public Health and Pharmacy have been selected to lead four projects backed by approximately $16 million in federal stimulus funding for comparative-effectiveness research in cancer.
The November 21 cover story of Forbes magazine profiles Bill Gates, Microsoft founder and co-chair of the Bill & Melinda Gates Foundation, which has focused its global health efforts on vaccine development and distribution, according to the article.
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced positive results from the Phase 1 portion of its Phase 1/1b study of defactinib (VS-6063) in combination with paclitaxel in patients with ovarian cancer that were presented at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston.
› Verified 6 days ago
| Entity Name | Abingdon Physician Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306944350 PECOS PAC ID: 5991705667 Enrollment ID: O20070102000365 |
News Archive
The American Diabetes Association and Good Measures, LLC today announced a new collaboration to help prevent and delay the onset of type 2 diabetes in the more than 84 million Americans currently living with prediabetes.
Today, The Endocrine Society unveiled its newest journal, Hormones & Cancer. This bi-monthly journal will include research articles covering all aspects of hormone action on cancer causation, progression, dependence, prevention, resistance and treatment.
Researchers at Fred Hutchinson Cancer Research Center, Group Health Research Institute and the University of Washington schools of Public Health and Pharmacy have been selected to lead four projects backed by approximately $16 million in federal stimulus funding for comparative-effectiveness research in cancer.
The November 21 cover story of Forbes magazine profiles Bill Gates, Microsoft founder and co-chair of the Bill & Melinda Gates Foundation, which has focused its global health efforts on vaccine development and distribution, according to the article.
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced positive results from the Phase 1 portion of its Phase 1/1b study of defactinib (VS-6063) in combination with paclitaxel in patients with ovarian cancer that were presented at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston.
› Verified 6 days ago
| Entity Name | Savida Health, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548739170 PECOS PAC ID: 4082809967 Enrollment ID: O20190426001267 |
News Archive
The American Diabetes Association and Good Measures, LLC today announced a new collaboration to help prevent and delay the onset of type 2 diabetes in the more than 84 million Americans currently living with prediabetes.
Today, The Endocrine Society unveiled its newest journal, Hormones & Cancer. This bi-monthly journal will include research articles covering all aspects of hormone action on cancer causation, progression, dependence, prevention, resistance and treatment.
Researchers at Fred Hutchinson Cancer Research Center, Group Health Research Institute and the University of Washington schools of Public Health and Pharmacy have been selected to lead four projects backed by approximately $16 million in federal stimulus funding for comparative-effectiveness research in cancer.
The November 21 cover story of Forbes magazine profiles Bill Gates, Microsoft founder and co-chair of the Bill & Melinda Gates Foundation, which has focused its global health efforts on vaccine development and distribution, according to the article.
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced positive results from the Phase 1 portion of its Phase 1/1b study of defactinib (VS-6063) in combination with paclitaxel in patients with ovarian cancer that were presented at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Matthew Gardner, MD 613 Campus Dr, Suite 200, Abingdon, VA 24210-9703 Ph: (276) 628-1186 | Dr James Matthew Gardner, MD 613 Campus Dr, Suite 200, Abingdon, VA 24210-9703 Ph: (276) 628-1186 |
News Archive
The American Diabetes Association and Good Measures, LLC today announced a new collaboration to help prevent and delay the onset of type 2 diabetes in the more than 84 million Americans currently living with prediabetes.
Today, The Endocrine Society unveiled its newest journal, Hormones & Cancer. This bi-monthly journal will include research articles covering all aspects of hormone action on cancer causation, progression, dependence, prevention, resistance and treatment.
Researchers at Fred Hutchinson Cancer Research Center, Group Health Research Institute and the University of Washington schools of Public Health and Pharmacy have been selected to lead four projects backed by approximately $16 million in federal stimulus funding for comparative-effectiveness research in cancer.
The November 21 cover story of Forbes magazine profiles Bill Gates, Microsoft founder and co-chair of the Bill & Melinda Gates Foundation, which has focused its global health efforts on vaccine development and distribution, according to the article.
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced positive results from the Phase 1 portion of its Phase 1/1b study of defactinib (VS-6063) in combination with paclitaxel in patients with ovarian cancer that were presented at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston.
› Verified 6 days ago
Jacquelyn Burt, Family Medicine Medicare: Medicare Enrolled Practice Location: 24530 Falcon Place Blvd, Suite 100, Abingdon, VA 24211 Phone: 276-619-0075 Fax: 276-619-0077 | |
Lura S Miller, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 613 Campus Dr, Suite 200, Abingdon, VA 24210 Phone: 276-628-1186 Fax: 276-628-8507 | |
Kaley Kuntz, Family Medicine Medicare: Medicare Enrolled Practice Location: 613 Campus Dr Ste 200, Abingdon, VA 24210 Phone: 276-628-1186 Fax: 276-628-8507 | |
Nermene George Wilson, MD Family Medicine Medicare: Medicare Enrolled Practice Location: Primary Care Center, 613 Campus Drive Suite #200, Abingdon, VA 24210 Phone: 714-326-6001 | |
Dr. Kellie Miranda Smith Blackwell, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 117 Cook St, Abingdon, VA 24210 Phone: 276-619-5052 Fax: 276-619-5115 | |
William M Handy, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 389 Falls Nwdr, Abingdon, VA 24210 Phone: 276-623-0740 Fax: 276-623-0660 | |
Lauren Ashley Mcgee, D.O Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 16000 Johnston Memorial Dr, Abingdon, VA 24211 Phone: 276-258-4435 |